Mutual of America Capital Management LLC Sells 1,934 Shares of Azenta, Inc. (NASDAQ:AZTA)

Mutual of America Capital Management LLC decreased its holdings in Azenta, Inc. (NASDAQ:AZTA) by 4.9% in the 4th quarter, HoldingsChannel reports. The firm owned 37,351 shares of the company’s stock after selling 1,934 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Azenta were worth $2,433,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Citigroup Inc. raised its position in Azenta by 558.8% in the 3rd quarter. Citigroup Inc. now owns 88,078 shares of the company’s stock valued at $4,421,000 after purchasing an additional 74,708 shares during the last quarter. Millrace Asset Group Inc. bought a new stake in shares of Azenta during the third quarter worth $1,074,000. Trexquant Investment LP bought a new stake in shares of Azenta during the third quarter worth $860,000. Invesco Ltd. raised its position in shares of Azenta by 35.4% during the third quarter. Invesco Ltd. now owns 331,012 shares of the company’s stock worth $16,613,000 after acquiring an additional 86,477 shares during the last quarter. Finally, Aigen Investment Management LP bought a new stake in shares of Azenta during the third quarter worth $220,000. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Up 0.3 %

Shares of Azenta stock opened at $50.65 on Friday. Azenta, Inc. has a 12 month low of $36.01 and a 12 month high of $69.16. The business has a fifty day simple moving average of $60.68 and a 200 day simple moving average of $58.92. The stock has a market cap of $2.82 billion, a PE ratio of -163.38 and a beta of 1.53.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 EPS for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The business had revenue of $154.32 million during the quarter, compared to analysts’ expectations of $151.86 million. Analysts expect that Azenta, Inc. will post 0.27 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on AZTA. Needham & Company LLC restated a “buy” rating and set a $75.00 target price on shares of Azenta in a research report on Monday, April 8th. Evercore ISI dropped their target price on Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research report on Thursday, April 4th. B. Riley boosted their target price on Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. Stephens reaffirmed an “equal weight” rating and set a $70.00 price objective on shares of Azenta in a research note on Thursday, February 8th. Finally, Jefferies Financial Group started coverage on Azenta in a research note on Thursday, April 4th. They set a “hold” rating and a $64.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $69.60.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.